False
May 11, 2026
As regulators move away from animal testing, scalable organoid platforms and standardized iPSC inputs could help close the gap between preclinical models and human biology
4 min read
May 11, 2026
First CAR-T approach for Alzheimer’s reduces amyloid plaques in mice, while cell and gene therapies advance across blood cancers, retinal disease, amyloidosis, and FSHD
6 min read
May 7, 2026
Comprehensive review highlights label-free viral detection – and the hurdles to real-world deployment
2 min read
May 6, 2026
IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to explore advances in scaling cell and gene therapies
May 5, 2026
How tariff uncertainty and geopolitical tensions are reshaping pharmaceutical logistics
6 min read
May 5, 2026
Plus: NICE backs rozanolixizumab for uncontrolled gMG, Genexine reports SOX2 degrader data, and BeOne secures option on Huahui trispecific antibody
4 min read
May 4, 2026
How CRO selection significantly influences study outcomes
6 min read
May 4, 2026
Intellia’s one-time HAE therapy delivers strong results as Cabaletta strikes CAR-T manufacturing deal
6 min read
May 1, 2026
Our gurus return to discuss future directions for nitrosamine analysis and regulation within the pharmaceutical industry
3 min read
April 30, 2026
As the sector matures, scalable vector production and robust analytical control are becoming essential to clinical and commercial success
7 min read
False